InsiderClue
Insiders · Profile

Lynx1 Capital Management LP

10% owner at Korro Bio · 10% owner at Passage BIO · 10% owner at TScan Therapeutics · and 2 more. Filing since 31 May 2023. CIK 0001910456

KRRO Korro Bio, Inc. 10% owner · 3 trades PASG Passage BIO, Inc. 10% owner · 11 trades TCRX TScan Therapeutics, Inc. 10% owner · 9 trades CGEM Cullinan Therapeutics, Inc. 10% owner · 8 trades NEUP Neuphoria Therapeutics Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
KRRO Korro Bio, Inc.
10 Aug 2026
10% owner
Bought
1,462
$19.28K
0.1%
KRRO Korro Bio, Inc.
6 Aug 2026
10% owner
Bought
5,222
$59.53K
0.3%
PASG Passage BIO, Inc.
25 Jun 2026
10% owner
Bought
50,055
$206.10K
8.0%
KRRO Korro Bio, Inc.
31 Mar 2026
10% owner
Bought
520
$5.51K
0.0%
TCRX TScan Therapeutics, Inc.
23 Dec 2025
10% owner
Bought
6,232
$5.60K
0.1%
TCRX TScan Therapeutics, Inc.
22 Dec 2025
10% owner
Bought
75,500
$67.95K
1.0%
TCRX TScan Therapeutics, Inc.
19 Dec 2025
10% owner
Bought
80,069
$71.97K
1.0%
CGEM Cullinan Therapeutics, Inc.
28 Oct 2025
10% owner
Bought
165,667
$1.39M
1.9%
NEUP Neuphoria Therapeutics Inc.
21 Oct 2025
10% owner
Bought
639,110
$3.28M
271%
CGEM Cullinan Therapeutics, Inc.
17 Oct 2025
10% owner
Bought
32,217
$252.57K
0.4%
CGEM Cullinan Therapeutics, Inc.
16 Oct 2025
10% owner
Bought
150,000
$1.33M
1.7%
CGEM Cullinan Therapeutics, Inc.
15 Oct 2025
10% owner
Bought
51,500
$409.05K
0.6%
CGEM Cullinan Therapeutics, Inc.
14 Oct 2025
10% owner
Bought
15,032
$114.05K
0.2%
CGEM Cullinan Therapeutics, Inc.
10 Oct 2025
10% owner
Bought
277,298
$2.04M
3.4%
CGEM Cullinan Therapeutics, Inc.
9 Oct 2025
10% owner
Bought
626,043
$4.19M
8.2%
CGEM Cullinan Therapeutics, Inc.
8 Oct 2025
10% owner
Bought
556,300
$3.59M
7.8%
PASG Passage BIO, Inc.
15 Sep 2025
10% owner
Bought
11,900
$83.18K
1.9%
PASG Passage BIO, Inc.
12 Sep 2025
10% owner
Bought
19,783
$138.30K
3.3%
PASG Passage BIO, Inc.
11 Sep 2025
10% owner
Bought
325
$2.26K
0.1%
PASG Passage BIO, Inc.
24 Jul 2025
10% owner
Bought
66,423
$379.45K
12.6%
PASG Passage BIO, Inc.
23 Jul 2025
10% owner
Bought
49,302
$283.03K
10.4%
PASG Passage BIO, Inc.
22 Jul 2025
10% owner
Bought
13,123
$71.34K
2.8%
TCRX TScan Therapeutics, Inc.
20 May 2025
10% owner
Bought
1,200,000
$1.44M
17.8%
TCRX TScan Therapeutics, Inc.
19 May 2025
10% owner
Bought
1,388,794
$1.67M
25.9%
PASG Passage BIO, Inc.
27 Dec 2024
10% owner
Bought
373,645
$241.04K
4.2%
TCRX TScan Therapeutics, Inc.
13 Dec 2024
10% owner
Bought
100,000
$290.14K
1.9%
TCRX TScan Therapeutics, Inc.
12 Dec 2024
10% owner
Bought
31,800
$95.63K
0.6%
PASG Passage BIO, Inc.
27 Nov 2024
10% owner
Bought
29,300
$19.66K
0.3%
PASG Passage BIO, Inc.
26 Nov 2024
10% owner
Bought
167,055
$118.19K
1.9%
PASG Passage BIO, Inc.
25 Nov 2024
10% owner
Bought
259,998
$146.66K
3.1%
TCRX TScan Therapeutics, Inc.
15 Nov 2024
10% owner
Bought
947
$4.11K
0.0%
TCRX TScan Therapeutics, Inc.
31 May 2023
10% owner
Sold at will
25,400
$63.95K
0.5%
32 decisions on file.